Header Logo

Connection

Weiyi Peng to Humans

Back to Details
This is a "connection" page, showing publications Weiyi Peng has written about Humans.
Weiyi Peng
Connection Strength
0.669
Humans
  1. MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumors. J Immunother Cancer. 2024 Sep 23; 12(9).
    View in: PubMed
    Score: 0.091
  2. Integrated multi-omics analyses identify anti-viral host factors and pathways controlling SARS-CoV-2 infection. Nat Commun. 2024 01 02; 15(1):109.
    View in: PubMed
    Score: 0.087
  3. Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses. Cancer Immunol Res. 2022 Apr 01; 10(4):420-436.
    View in: PubMed
    Score: 0.077
  4. LIMITing tumours with an immunogenic lncRNA. Nat Cell Biol. 2021 05; 23(5):443-445.
    View in: PubMed
    Score: 0.072
  5. Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulators. J Immunother Cancer. 2021 02; 9(2).
    View in: PubMed
    Score: 0.071
  6. Development of a RIPK1 degrader to enhance antitumor immunity. Nat Commun. 2024 Dec 16; 15(1):10683.
    View in: PubMed
    Score: 0.023
  7. UBA1 inhibition sensitizes cancer cells to PARP inhibitors. Cell Rep Med. 2024 Dec 17; 5(12):101834.
    View in: PubMed
    Score: 0.023
  8. IRE1a silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer. Cell. 2024 Dec 12; 187(25):7248-7266.e34.
    View in: PubMed
    Score: 0.023
  9. Lymphocyte-Activation Gene 3 Facilitates Pathological Tau Neuron-to-Neuron Transmission. Adv Sci (Weinh). 2024 Apr; 11(16):e2303775.
    View in: PubMed
    Score: 0.022
  10. PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition. Cell Rep Med. 2023 Dec 19; 4(12):101326.
    View in: PubMed
    Score: 0.022
  11. Multiplatform Analysis of Intratumoral PTEN Heterogeneity in Melanoma. J Invest Dermatol. 2023 Sep; 143(9):1779-1787.e1.
    View in: PubMed
    Score: 0.020
  12. Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma. Clin Cancer Res. 2023 Jan 04; 29(1):154-164.
    View in: PubMed
    Score: 0.020
  13. 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy. Nat Commun. 2021 Sep 23; 12(1):5606.
    View in: PubMed
    Score: 0.018
  14. Development of Immunotherapy Combination Strategies in Cancer. Cancer Discov. 2021 Jun; 11(6):1368-1397.
    View in: PubMed
    Score: 0.018
  15. The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell-Mediated Immunotherapies. Mol Cancer Ther. 2021 Mar; 20(3):500-511.
    View in: PubMed
    Score: 0.018
  16. Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity. Cancer Immunol Immunother. 2021 Apr; 70(4):1101-1113.
    View in: PubMed
    Score: 0.017
  17. 18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer. Cancer Immunol Immunother. 2020 Aug; 69(8):1519-1534.
    View in: PubMed
    Score: 0.017
  18. A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma. Clin Cancer Res. 2019 Nov 01; 25(21):6429-6442.
    View in: PubMed
    Score: 0.016
  19. CXCR5+CD8+ T cells are a distinct functional subset with an antitumor activity. Leukemia. 2019 Nov; 33(11):2640-2653.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.